CONSULTANT CONNECTION |
Learn about the importance of immune monitoring in determining
safety and efficacy in this issue of Consultant Connection. |
This year alone, 3,984 products in drug development R&D pipelines, representing six of the top 25 therapeutic agent categories, were vaccines and immunotherapeutics—a 12 percent increase from 2015 (source: Pharmaprojects). Much of this growth was driven by innovation from small and mid-sized biopharmaceutical organizations that may not have all of the information that they need to understand how current decisions impact future clinical trials. With immunotherapeutics and vaccines in particular, employing the right immune monitoring technique—at the right time—is essential to accurately characterize the effectiveness of a therapeutic approach in clinical trials. Areas of focus for your client should be: |
What Your Clients Need to Know About Vaccine and Novel |
|
While successful immune monitoring involves a number of techniques, employing the right technique—at the right time—is essential for your client to accurately characterize the effectiveness of their therapeutic approach in clinical trials. Read the full Whitepaper and contact us today to get started with our Vaccine and Novel Immunotherapeutic Laboratory Solutions team, an expert mix of lab scientists and study managers dedicated exclusively to vaccine and immunotherapeutics, who can accelerate your client’s program in this specialized area of development. |
Past Consultant Connection Articles |
Vaccine and Immunotherapeutic Resources |
The Consultant Connection is a unique communication tool focused on your point of view as a consultant, featuring Covance solutions that can help you and your clients to be more productive and successful. |